(相关资料图)

CFi.CN讯：中国医药（股票代码：600056）公布2025年半年度报告摘要。

调整后调整前上年同期增减(%)营业收入17,075,860,112.1618,304,053,128.9117,797,322,228.73-6.71利润总额520,722,428.39626,603,047.71604,023,833.45-16.90归属于上市公司股东的净利润293,959,402.72350,761,696.96325,119,038.69-16.19归属于上市公司股东的扣除非经常性损益的净利润255,736,026.62287,492,808.06287,492,808.06-11.05经营活动产生的现金流量净额-546,132,971.53-743,074,836.88-686,137,723.53不适用加权平均净资产收益率（%）2.413.032.85减少0.62个百分点基本每股收益（元／股）0.19650.23450.2173-16.20稀释每股收益（元／股）0.19650.23450.2173-16.20